Schizophrenia for "Life" - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02246283|
Recruitment Status : Completed
First Posted : September 22, 2014
Last Update Posted : July 17, 2018
The elderly demographic is on the rise - and this includes elderly living with schizophrenia. Yet very little is known about their lives, how they cope with their condition and how it develops over time.
Research in this patient-group is sparse; overall there seem to be a tendency for elderly patients to manifest fewer psychotic symptoms and experiencing an increase in the psychological quality of life with older age. Opinions are divided on the degree and extent to which this tendency reflects remission and/or recovery in older patients.
In order to identify factors associated with a positive outcome we:
- Investigate the course and the outcomes of the illness over the lifespan, as well as the life course and outcomes.
- Investigate the current status of mental and physical health, quality of life as well as functional competence of elderly (55+ yr) with schizophrenia.
Also the investigators
- Compare the trajectory and prognosis of schizophrenia (a chronic mental illness) with type 1 diabetes (a chronic somatic illness).
This study will yield vital insights into how schizophrenia develops over time, isolating factors that determine how well patients fare. The perspective is to advance knowledge of elderly with schizophrenia with a view to optimizing and increasing the effectiveness of the interventions offered to this group.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||10404 participants|
|Official Title:||Schizophrenia for "Life" - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia|
|Study Start Date :||September 2013|
|Actual Primary Completion Date :||September 2015|
|Actual Study Completion Date :||December 2017|
- Ageing with schizophrenia [ Time Frame: up to 45 years ]Prognosis measured by use of healthcare system, use of medicine, co-morbidity, mortality, causes of mortality, and socio-demographic data, including highest level of education, years of employment/un-employment, use of health- and welfare services.
- Quality of life [ Time Frame: 1 month ]Questionnaire
- Remission [ Time Frame: 6 months ]Questionnaire
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02246283
|Research Unit of Psychiatry, Psychiatric Unit Odense - University function|
|Odense C, Denmark, 5000|
|Principal Investigator:||Maria Brink, MD||University of Southern Denmark|